| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3608985
Max Phase: Preclinical
Molecular Formula: C16H12ClN3OS
Molecular Weight: 329.81
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: Nc1cccc(Nc2ncc(C(=O)c3ccccc3Cl)s2)c1
Standard InChI: InChI=1S/C16H12ClN3OS/c17-13-7-2-1-6-12(13)15(21)14-9-19-16(22-14)20-11-5-3-4-10(18)8-11/h1-9H,18H2,(H,19,20)
Standard InChI Key: VXYRVNRBVKHYQL-UHFFFAOYSA-N
Associated Targets(Human)
MAP kinase p38 1586 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 329.81 | Molecular Weight (Monoisotopic): 329.0390 | AlogP: 4.35 | #Rotatable Bonds: 4 |
| Polar Surface Area: 68.01 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 12.71 | CX Basic pKa: 4.24 | CX LogP: 4.12 | CX LogD: 4.12 |
| Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.55 | Np Likeness Score: -1.76 |
References
| 1. Park H, Lee S, Hong S.. (2015) Structure-based de novo design and synthesis of aminothiazole-based p38 MAP kinase inhibitors., 25 (18): [PMID:26259807] [10.1016/j.bmcl.2015.07.094] |
Source
Source(1):